On Monday, Vera Therapeutics Inc (NASDAQ: VERA) was 3.92% up from the session before settling in for the closing price of $28.35. A 52-week range for VERA has been $18.53 – $51.27.
Annual sales at Healthcare sector company grew by 4.49% over the past five years. When this article was written, the company’s average yearly earnings per share was at -67.26%. With a float of $48.98 million, this company’s outstanding shares have now reached $63.89 million.
Vera Therapeutics Inc (VERA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vera Therapeutics Inc stocks. The insider ownership of Vera Therapeutics Inc is 23.38%, while institutional ownership is 89.56%. The most recent insider transaction that took place on Nov 11 ’25, was worth 435,874. In this transaction SVP, FINANCE, CHIEF ACCT OFFCR of this company sold 15,000 shares at a rate of $29.06, taking the stock ownership to the 47,839 shares. Before that another transaction happened on Jun 23 ’25, when Company’s Director bought 209,393 for $20.87, making the entire transaction worth $4,369,676. This insider now owns 3,569,522 shares in total.
Vera Therapeutics Inc (VERA) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.72 earnings per share (EPS) during the time that was better than consensus figure (set at -0.73) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -67.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.35% during the next five years compared to 4.49% growth over the previous five years of trading.
Vera Therapeutics Inc (NASDAQ: VERA) Trading Performance Indicators
You can see what Vera Therapeutics Inc (VERA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 12.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.99, a number that is poised to hit -1.30 in the next quarter and is forecasted to reach -4.85 in one year’s time.
Technical Analysis of Vera Therapeutics Inc (VERA)
Vera Therapeutics Inc (NASDAQ: VERA) saw its 5-day average volume 1.63 million, a positive change from its year-to-date volume of 1.39 million. As of the previous 9 days, the stock’s Stochastic %D was 64.91%.
During the past 100 days, Vera Therapeutics Inc’s (VERA) raw stochastic average was set at 79.02%, which indicates a significant increase from 73.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.19 in the past 14 days, which was higher than the 1.29 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.07, while its 200-day Moving Average is $25.27. Nevertheless, the first resistance level for the watch stands at $30.29 in the near term. At $31.12, the stock is likely to face the second major resistance level. The third major resistance level sits at $32.34. If the price goes on to break the first support level at $28.24, it is likely to go to the next support level at $27.02. Assuming the price breaks the second support level, the third support level stands at $26.19.
Vera Therapeutics Inc (NASDAQ: VERA) Key Stats
There are 63,824K outstanding shares of the company, which has a market capitalization of 1.88 billion. As of now, sales total 0 K while income totals -152,150 K. Its latest quarter income was 0 K while its last quarter net income were -80,290 K.
